Expanding Diagnostic Capabilities Inform Diagnostics offers a broad range of pathology and molecular diagnostic services, including infectious disease testing and genetic analysis. This extensive portfolio presents opportunities to upsell specialized tests and expand service offerings to existing hospital and healthcare clients seeking comprehensive diagnostic solutions.

Growth Through Acquisitions Having been acquired by Fulgent Genetics and with recent strategic partnerships, the company is in a growth phase that may involve expanding its client base. Targeting regional hospitals and healthcare networks interested in expanding their pathology services could facilitate new sales engagements.

Technological Edge Utilizing advanced tech stacks such as Hyperion, SAP, and cloud management tools, Inform Diagnostics emphasizes innovation in diagnostic processes. Selling complementary healthcare IT solutions, laboratory automation tools, or data integration services could complement their technological infrastructure.

Regulatory and Quality Focus Despite facing billing fraud allegations and legal challenges, the company’s strong emphasis on quality and accuracy in diagnostics signals an openness to compliance solutions, risk management services, and legal consulting that could support their ongoing compliance and operational integrity.

Market Position and Revenue With revenues estimated between 100 million and 250 million and a sizable workforce, Inform Diagnostics is positioned as a key player in healthcare diagnostics. This stability provides an opportunity to offer value-added services such as laboratory management, employee training programs, or expansion into new diagnostic areas to support their growth.